[go: up one dir, main page]

JPH02268765A - Hyaluronate sheet and preparation thereof - Google Patents

Hyaluronate sheet and preparation thereof

Info

Publication number
JPH02268765A
JPH02268765A JP1089683A JP8968389A JPH02268765A JP H02268765 A JPH02268765 A JP H02268765A JP 1089683 A JP1089683 A JP 1089683A JP 8968389 A JP8968389 A JP 8968389A JP H02268765 A JPH02268765 A JP H02268765A
Authority
JP
Japan
Prior art keywords
hyaluronate
sheet
fibers
water
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1089683A
Other languages
Japanese (ja)
Other versions
JPH0622560B2 (en
Inventor
Hiromi Sugitani
広美 杉谷
Tomohiro Sugitani
杉谷 智博
Takashi Nozawa
孝志 野澤
Minoru Hara
實 原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kibun KK
Kikkoman Soyfoods Co
Original Assignee
Kibun Food Chemifa KK
Kibun KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kibun Food Chemifa KK, Kibun KK filed Critical Kibun Food Chemifa KK
Priority to JP1089683A priority Critical patent/JPH0622560B2/en
Publication of JPH02268765A publication Critical patent/JPH02268765A/en
Publication of JPH0622560B2 publication Critical patent/JPH0622560B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Materials For Medical Uses (AREA)

Abstract

PURPOSE:To obtain an excellent covering and protecting material for skin damage by introducing a hyaluronic acid aq. soln. in a solvent in such a way that the final concn. of a water-soluble org. solvent is a specified value to coagulate and deposit a fibrous hyaluronate, grinding it in the liq. into single fibers, making them into a sheet and drying it. CONSTITUTION:A hyaluronate aq. soln. is introduced in a solvent ao as to obtain the final concn. of a water-soluble org. solvent of 50v/v% or higher and a fibrous hyaluronate is coagulated and deposited. The fibrous hyaluronate is ground in a liq. into single fibers, which are then made in a sheet and the sheet is dried to obtain a sheet. If the final concn. of the water-soluble org. solvent is not kept at 50v/v% or higher, the hyaluronate is not deposited into a fibrous state and it is not pref. As the hyaluronate fiber has self-adhesive characteristics, the hyaluronate fibers adhere and bind each other and the hyaluronate fibers sheet exhibits excellent strength, excellent water absorption proparties, water retention and moisture retention as well as excellent biocompatibility. When the sheet is used as a covering and protecting material for skin damage, it absorbs and holds rapidly. a liq. oozing out of the diseased part to accelerate a skin formation and the condition of the skin after curing is smooth to obtain a good effect.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明はヒアルロン酸塩シート及びその製造方法並びに
その用途に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a hyaluronate sheet, a method for producing the same, and uses thereof.

〔従来の技術) 悲傷等の傷痕の成形のためになされた植皮部もしくはそ
のために発生した採皮部等の皮膚欠損傷の治療のため、
従来から被覆保護材が用いられてきた。それらの中で古
くから最も一般的なものは医療用ガーゼもしくは医療用
不織布であるが、これらは創傷部に付着しやすく無理に
剥離すると又傷が付いてしまうという問題点があった。
[Prior art] For the treatment of skin defects such as skin grafts made for shaping scars such as tragic injuries, or skin harvesting parts that occur as a result,
Conventionally, protective coatings have been used. Among them, medical gauze and medical nonwoven fabric have been the most common since ancient times, but these have the problem that they tend to adhere to the wound area and if they are forcibly removed, they will cause further damage.

そこで、これらの問題点のないより優れた皮膚欠@傷用
被覆保護材を提供覆べく、生体適合性の優れた天然物由
来の素材からなる該保護材が開発されている。例えば甲
殻類の外骨格等に含まれているアミン多糖類の1種であ
るキチンの繊維からなる不織布や、]ラーグン不織布、
或いは凍結豚皮等がそれである。
Therefore, in order to provide a better covering and protecting material for skin defects/wounds that does not have these problems, a protecting material made of a material derived from a natural product with excellent biocompatibility has been developed. For example, nonwoven fabrics made of fibers of chitin, which is a type of amine polysaccharide contained in the exoskeletons of crustaceans, ragun nonwoven fabrics,
Or frozen pork skin etc.

しかし、これらはいずれも創面への密着性が充分でなく
患部に浸出液が貯留しやすい他、治癒後の皮膚の状態も
よくないという問題点があり、又、資源の面からも充分
な量産が鉗しいという問題点を抱えていた。
However, all of these have the problem of insufficient adhesion to the wound surface, which tends to cause exudate to accumulate in the affected area, and the condition of the skin after healing is also poor.In addition, sufficient mass production is not possible due to resource constraints. It had the problem of being stiff.

一方、ヒアルロン酸は硝子体、へその緒、皮膚、ニワト
リのトサカ等の動物組織に分!5シている多糖類であっ
て、近年その特性を利用して化粧品、医薬等に利用され
るようになってきており、特にヒアルロン酸の醗酵法に
よる製法が開発されてからはその用途開発も一段と盛ん
になっているものである。
On the other hand, hyaluronic acid is distributed in animal tissues such as the vitreous body, umbilical cord, skin, and chicken crest! It is a polysaccharide with five types of fibers, and in recent years it has been used in cosmetics, medicine, etc. by taking advantage of its properties, and in particular, since the development of a fermentation method for hyaluronic acid, the use of hyaluronic acid has been developed. It is something that is becoming more and more popular.

しかしながら、このヒアルロン酸及びその塩そのものを
直接上記の皮膚欠損傷用被覆保護材に用いようとする試
みは今までなかった。ちなみに、これに近い技術として
特開昭61−187866号公報に医療用ガーピまたは
医療用不織布にヒアルロン酸又はその塩を0601〜2
,0重M%になるように表面処理することを特徴とする
医療用被覆材が開示されているがこれもヒアルロン酸塩
それ自体からなる創傷被覆保護材ではない。
However, there has been no attempt to directly use this hyaluronic acid and its salt itself in the above-mentioned covering and protecting material for skin defects and injuries. Incidentally, as a technology similar to this, Japanese Patent Application Laid-open No. 187866/1986 describes a technique in which hyaluronic acid or its salts are applied to medical garpi or medical nonwoven fabric.
, 0% by weight has been disclosed, but this is also not a wound dressing protection material made of hyaluronate itself.

〔発明が解決しようとする課題〕[Problem to be solved by the invention]

本発明は上記した事情に鑑みて、生体適合性があり、皮
膚欠損傷或いは創傷等の人体表面部の患部への密着性に
優れ、保湿性なども良好で、冶1)&後の表皮の状態も
なめらかになるような優れた皮膚欠損傷被覆保護材の開
発を目的になされlこものである。
In view of the above circumstances, the present invention is biocompatible, has excellent adhesion to affected parts of the human body surface such as skin defects or wounds, has good moisturizing properties, and has the following properties: This work was done with the aim of developing an excellent covering and protecting material for skin defects and injuries that would smooth the skin's condition.

(課題を解決するための手段) 本発明者らは以前よりωI究してきたヒアルロン酸塩が
本来有している保湿性、保水性及び生体への親和性に着
目し、これを利用すると極めて優れた皮膚欠損傷に対す
る被覆保護材になり得るという知見を得るとともにヒア
ルロン酸塩のシー1−化技術を開発し、本発明に到達し
た。
(Means for Solving the Problems) The present inventors have focused on the inherent moisturizing properties, water-retaining properties, and affinity for living organisms of hyaluronate, which has been studied for ωI for some time. The present invention was achieved by obtaining the knowledge that the present invention can be used as a covering and protecting material for skin defects and injuries, and by developing a technology for converting hyaluronate into a 1-layer material.

すなわち本発明は、ヒアル[1ン酸塩の繊維からなるシ
ート及び該シートを製造するために水溶性有機溶媒の最
終濃度が50 v/v%以上になるように該溶媒中にヒ
アルロン酸水溶液を導入し、繊維状ヒアルロン酸塩を凝
固析出せしめ、次いで液中で破砕して単繊維にした後、
これを抄造し、乾燥することを特徴とする該シートの製
造方法を提供するものである。
That is, the present invention provides a sheet made of fibers of hyal monophosphate, and in order to produce the sheet, an aqueous hyaluronic acid solution is added to the water-soluble organic solvent so that the final concentration is 50 v/v% or more. After introducing the fibrous hyaluronate and coagulating and precipitating the fibrous hyaluronate, the fibrous hyaluronate is crushed into single fibers in the liquid.
The present invention provides a method for producing the sheet, which is characterized by forming the sheet into paper and drying it.

以下本発明の詳細な説明する。The present invention will be explained in detail below.

ヒアルロン酸は硝子体、へその緒、皮膚、ニワ1〜りの
トリ力等に含まれているグリコリミノグリカンの1種で
ある。
Hyaluronic acid is a type of glycoliminoglycan contained in the vitreous body, umbilical cord, skin, chickens, etc.

本発明においてはこのヒアルロン酸塩を原料として用い
る。ヒアルロン酸塩としては好ましくはナトリウム、カ
リウム、カルシウムの塩であり、特に好ましくはナトリ
ウム塩である。
In the present invention, this hyaluronate is used as a raw material. The hyaluronate is preferably a sodium, potassium or calcium salt, and particularly preferably a sodium salt.

ヒアルロン酸塩を製造するには動物組織、例えばニワト
リのトサカ、へその緒などを細砕した後、プロデアーピ
や溶媒処理によりタンパク質等の不純物を除き、硫酸ア
ンモニウムで分別沈澱を行い製造するか、近年発展した
ヒアルロン酸生産菌を利用した醗酵法により製造するこ
とができる。
To produce hyaluronate, animal tissues such as chicken crests and umbilical cords are crushed, and impurities such as proteins are removed by prodiaepidermy or solvent treatment, followed by fractional precipitation with ammonium sulfate. It can be produced by a fermentation method using acid-producing bacteria.

いずれの方法によるとしても用いるヒアルロン酸塩は充
分精製し、純瓜の高いものを用いる必要がある。
Regardless of the method used, the hyaluronate used must be sufficiently purified and of high purity.

このヒアルロン酸塩を次に示す方法にで繊維状にづる。This hyaluronate is made into a fiber by the following method.

すなわち、まずヒアルロン酸塩、例えばヒアル[1ン酸
ナトリウム等を水に溶解し、0.1〜2.OW/V%の
水溶液とする。該ヒアルロン酸塩水溶液の81反は0.
1W/V%未満では粉末化して濾取脱水が困難になるの
で好ましくなく、又2.OW/V%を越えると析出沈澱
はづるものの内部流動性のLり一状となってしまうので
好ましくない。
That is, first, a hyaluronate, such as sodium hyal[1 phosphate, etc., is dissolved in water, and the solution is 0.1 to 2. It is made into an aqueous solution of OW/V%. 81 times of the hyaluronate aqueous solution is 0.
If it is less than 1 W/V%, it is not preferable because it becomes powder and filtering and dehydration becomes difficult. If the OW/V% is exceeded, the precipitate will form, but the internal fluidity will become uniform, which is not preferable.

この水溶液の粘度は0.1Δ/V%の時は200CI’
であるが、1.0W/V %)場合ハ25,000CP
テl)’Q、2.0ill/v%ノテハ250,0OO
CPトイウカなり粘稠な液となる。
The viscosity of this aqueous solution is 200CI' when it is 0.1Δ/V%
However, in the case of 1.0W/V %), 25,000CP
Tel)'Q, 2.0ill/v% Noteha 250,0OO
CP toiuka becomes a viscous liquid.

次にこのヒアルロン酸塩水溶液を水溶性有機溶媒の中に
入れると凝固してlIi維状となる。該繊維状物の構造
はより細いヒアルロン酸塩のvIA雑が互いに絡み合っ
た構造になっている。
Next, when this hyaluronate aqueous solution is placed in a water-soluble organic solvent, it coagulates to form IIi filaments. The structure of the fibrous material is such that thinner vIA particles of hyaluronate are intertwined with each other.

水溶性有機溶媒としてはメタノール、エタノール、アセ
トン、n−プロパツール、イソプロパツル、又はアセト
ニl−リルが好ましい。
Preferred water-soluble organic solvents are methanol, ethanol, acetone, n-propanol, isopropanol, or acetonyl-l-lyl.

又、水溶性有機溶媒の最終m度は50 v/v%以上、
好ましくは60〜80 v/v%、特に好ましくは70
〜75 v/v%である。すなわら、ヒアルロン酸塩水
溶液から加わる水分によって該溶媒の濃度は低下するの
であるが、50 v/v%以上を保っていないとヒアル
ロン酸塩が繊維状に析出してこなくなくなるので好まし
くない。
In addition, the final m degree of the water-soluble organic solvent is 50 v/v% or more,
Preferably 60-80 v/v%, particularly preferably 70
~75 v/v%. That is, the concentration of the solvent decreases due to water added from the hyaluronate aqueous solution, but unless the concentration is maintained at 50 v/v% or more, the hyaluronate will not precipitate in the form of fibers, which is not preferable.

ヒアルロン酸塩(ドープ)を凝固液である水溶性有機溶
媒中に導入する方法としては容器などから粘稠なヒアル
ロン酸塩水溶液を直接水あめ状に自然垂下することによ
り攪拌されている水溶性有機溶媒中に導入する方法もと
ることができるが、工業的にはギヤポンプ等を用いて径
が0.01〜0.5M程度のノズルから上記のドープを
凝固液中に吐出せしめて行うのがよい。
A method for introducing hyaluronate (dope) into a water-soluble organic solvent, which is a coagulating liquid, is to naturally drip a viscous hyaluronate aqueous solution directly from a container into a water-soluble organic solvent in the form of starch syrup. Although a method of introducing the dope into the coagulation liquid can also be used, industrially it is preferable to discharge the above-mentioned dope into the coagulation liquid from a nozzle with a diameter of about 0.01 to 0.5M using a gear pump or the like.

以上によって得られたI維状物はそのままではシート化
に適した状態になっていないので、細繊維が絡み合って
太い糸状をなしているものをほぐし、且つ良さもシート
化に適した2〜5M程度の短NMにする必要がある。繊
維の長さが上記範囲をはずれて短くなりすぎると綿状に
なりシート化が困難となり、一方長すぎると繊維同志が
分散媒中で塊状化し均一な分散が困難になるので好まし
くない。これに反して上記の2〜5mm程度の長さでは
シート内の繊維の絡みも適当となり、且つヒアルロン酸
塩繊維の特徴である自己接着性が有効に働いて14M間
の接着結合も良好となるという効果が得られる。
The I fibrous material obtained above is not in a state suitable for sheeting as it is, so the fine fibers are loosened to form a thick thread, and the quality is 2 to 5M, which is suitable for sheeting. It is necessary to make the NM relatively short. If the length of the fibers is too short outside the above range, the fibers will become fluffy and difficult to form into a sheet, while if the fibers are too long, the fibers will form lumps in the dispersion medium, making uniform dispersion difficult, which is not preferable. On the other hand, when the length is about 2 to 5 mm, the entanglement of the fibers within the sheet becomes appropriate, and the self-adhesive property, which is a characteristic of hyaluronate fibers, works effectively, resulting in good adhesive bonding between 14M. This effect can be obtained.

類1維化の方法としては公知の短繊維化技術が使用でき
るが、水溶性有機溶媒中で翼付きミキ1ノー例えばカッ
ターミキリーやジュー°リーミキサー等を用いて当該I
Ii維状物を細かく粉砕する方法が簡便である。この場
合、該ミキサーの回転数としては2000〜5000r
pm !!i!度が好ましく、時間は10〜30秒程度
がよい。又、短lli維化の際、使用する溶媒は紡糸に
使用した前記の水溶性有機溶媒が好適であり、その瀧麿
は90〜99 v/v%のものが好ましい。
As a method for forming Class 1 fibers, known shortening techniques can be used;
A method of finely pulverizing the Ii fibrous material is simple. In this case, the rotation speed of the mixer is 2000 to 5000 r.
PM! ! i! The time is preferably about 10 to 30 seconds. Further, when forming short LLI fibers, the solvent used is preferably the water-soluble organic solvent used for spinning, and the amount of water is preferably 90 to 99 v/v%.

以上によって得られたヒアルロン酸塩の短繊維からシー
I・を製造するには和紙の抄造と似た方法によって行う
ことができる。
C.I. can be produced from the short fibers of hyaluronate obtained in the above manner by a method similar to that used for making Japanese paper.

フなわら、まず水溶性有機溶媒等の分散液中で当該短繊
維を均一な分軟になるように攪拌した後、これを分散液
は通すが該短繊維は通さない固液分!1ift装置、例
えば各種濾材の上に必要聞流し込む。
First, the short fibers are stirred in a dispersion of a water-soluble organic solvent or the like so that they are uniformly softened, and then the solid-liquid content is passed through the dispersion but not the short fibers. 1ift device, for example, pour the necessary amount onto various filter media.

この際、厚みが平均的になるように流し込むことが好ま
しく、又吸引濾過の方式を用いると製造時間を短縮する
ことができる。
At this time, it is preferable to pour the material so that it has an average thickness, and if a suction filtration method is used, the production time can be shortened.

濾材は公知の濾紙、金網、濾布、セラミックもしくはプ
ラスチックフィルター等の中から適宜選択して使用すれ
ばよい。
The filter medium may be appropriately selected from among known filter paper, wire mesh, filter cloth, ceramic or plastic filters, and the like.

又短繊維を分散させておく分散液は、該短繊維を溶解も
しくは変14 t! Lめない溶媒ならいずれも使用で
きるが、紡糸及び短繊維化時に使用したのと同じ水溶性
有機溶媒を用いた方が回収再使用の際、経済的であり好
ましい。
In addition, the dispersion liquid in which the short fibers are dispersed dissolves or changes the short fibers.14 t! Although any solvent can be used as long as it does not cause sulfur, it is preferable to use the same water-soluble organic solvent used during spinning and short fiber formation because it is more economical for recovery and reuse.

このようにしてjqられだヒアルロン酸塩繊維シートは
いわゆる湿紙の状態となっている。該シート中に含まれ
る水分的は短繊維化時に使用した溶媒が90〜99 v
/v%とした場合通常1.0〜11.Ov/v%が好ま
しく、良好なシートを1qるため特に好ましい水分量は
5〜6 v/v%である。
In this way, the jq-dareda hyaluronate fiber sheet is in the state of a so-called wet paper. In terms of moisture contained in the sheet, the solvent used during short fiber formation is 90 to 99 v.
/v% is usually 1.0 to 11. Ov/v% is preferred, and a particularly preferred moisture content is 5 to 6 v/v% in order to obtain a good sheet.

この湿紙状シートを通常の乾燥機等を用いて乾燥すると
目的とするシートが得られる。この場合乾燥条f1は乾
燥温度が通常50〜90℃、好ましくは60〜80℃、
乾燥時間が30分〜60分である。
The desired sheet is obtained by drying this wet paper-like sheet using an ordinary dryer or the like. In this case, the drying temperature of the drying strip f1 is usually 50 to 90°C, preferably 60 to 80°C,
Drying time is 30 minutes to 60 minutes.

〔発明の効果〕〔Effect of the invention〕

本発明のヒアルロン酸塩Ili維シートはヒアルロン酸
塩繊維が自己接着性を有するため、一般の不織布で必須
の接着剤を使用しないにもかかわらず、各繊維が互いに
接着結合し、優れた強度を有している。又、このシート
はヒアルロン酸が天然物由来のものであり上記のように
接着剤の使用もないため、人体に対しては安全であり、
優れた吸、保水性並びに保湿性とともに生体への適合性
す優れているという効果が1ワられる。
In the hyaluronate Ili fiber sheet of the present invention, the hyaluronate fibers have self-adhesive properties, so each fiber is adhesively bonded to each other and has excellent strength, even though it does not use an adhesive that is essential for general nonwoven fabrics. have. In addition, this sheet is safe for the human body because the hyaluronic acid is derived from natural products and does not use adhesives as mentioned above.
It has the following effects: excellent absorption, water retention, and moisturizing properties, as well as excellent compatibility with living organisms.

したがって、これらの効果、特性を利用して本発明シー
トを皮膚欠損傷用被覆保愚材として用いた場合、患部か
ら滲み出す液体を素早く吸収、保持して表皮形成を促進
し、治癒後の表皮の状態もなめらかで良好−という効果
が得られる。
Therefore, when the sheet of the present invention is used as a covering material for damaged skin by utilizing these effects and characteristics, it quickly absorbs and retains the liquid exuding from the affected area, promotes epidermis formation, and improves the epidermis after healing. The effect is that the condition is smooth and good.

(実施例) 以下実施例で本発明を説明する。(Example) The present invention will be explained below with reference to Examples.

実施例1 ゆっくり攪拌されている95%メタノール1000rn
l中に粘稠なヒアルロン酸ノ°トリウムのI W/V%
水溶液300!Illを徐々に垂下しつつ導入すると、
直ちに凝固して繊維状物を形成する。この場合のメタノ
ールの最終:a度は約73 v/v%であった。
Example 1 95% methanol 1000 rn with slow stirring
I W/V% of viscous hyaluronate notorium in l
Aqueous solution 300! When Ill is gradually introduced while dripping,
It solidifies immediately to form a fibrous material. The final a degree of methanol in this case was approximately 73% v/v.

この繊維状物を液体から取り出し、濾別によって充分液
をしぼった後、再び95%メタノール500d中に入れ
、市販のジュースミキーリーを用い4130rpmで約
20秒激しく攪拌したところ、繊維状物は破砕され、長
さ2〜5馴の短繊維となった。
The fibrous material was taken out of the liquid, the liquid was sufficiently squeezed by filtration, and then placed in 500 d of 95% methanol and vigorously stirred for about 20 seconds at 4130 rpm using a commercially available Juice Mikili, the fibrous material was crushed. This resulted in short fibers with a length of 2 to 5 cm.

続いてこれを適麿に攪拌して、該短繊維が均一に分散さ
れた分散液(ドープ)を調製し、吸引濾過装置に設けら
れた直径150#の円形濾紙上に流し込むと湿紙様のシ
ートが得られた。
Next, this is stirred properly to prepare a dispersion (dope) in which the short fibers are uniformly dispersed, and poured onto a circular filter paper with a diameter of 150 # installed in a suction filtration device, resulting in a wet paper-like material. A sheet was obtained.

このシートを電熱式乾燥機に入れ60℃で30分間乾燥
すると直径150#の円形のヒアルロン酸ナトリウム繊
維シーi−が得られた。このシートは白色で濾紙のよう
な外観を持ら、厚さが約0.5#の均一なシートであっ
た。
This sheet was placed in an electric dryer and dried at 60° C. for 30 minutes to obtain a circular sodium hyaluronate fiber sheet I- with a diameter of 150#. This sheet was white and had the appearance of filter paper, and was a uniform sheet with a thickness of about 0.5#.

このシートから1.5CIiの試験片を切り取り、相対
湿度81%中に24時間放置した後の重量増加を測定し
その吸湿性を測定したところ18.7%であった。
A 1.5 CIi test piece was cut from this sheet, and the weight increase after leaving it for 24 hours in a relative humidity of 81% was measured, and its hygroscopicity was determined to be 18.7%.

又、巾2#の帯状試料を切り取り、両端を固定し一端に
おもりを加えて引っ張り、切れたとぎの荷重量によって
強度を測定したところ41.59 g重の強度があるこ
とがわかった。
In addition, a strip sample with a width of 2# was cut, both ends were fixed, a weight was added to one end, and the strength was measured by the amount of load at the cut end. It was found that the sample had a strength of 41.59 g.

特許出願人  株式会社 紀  文Patent applicant: Kibun Co., Ltd.

Claims (1)

【特許請求の範囲】 1、ヒアルロン酸塩の繊維からなるシート。 2、ヒアルロン酸塩がヒアルロン酸ナトリウム、ヒアル
ロン酸カリウム、及びヒアルロン酸カルシウムから選ば
れた1種以上である請求項1記載のシート。 3、水溶性有機溶媒の最終濃度が50v/v%以上にな
るように該溶媒中にヒアルロン酸塩水溶液を導入し、繊
維状になったヒアルロン酸塩を凝固析出せしめ、次いで
それを液中で破砕して短繊維にした後、該繊維を抄造し
、乾燥することを特徴とするヒアルロン酸塩の繊維から
なるシートの製造方法。 4、水溶性有機溶媒がメタノール、エタノール、アセト
ン、n−プロパノール、イソ−プロパノール、及びアセ
トニトリルから選ばれた1以上の溶媒であることを特徴
とする請求項3記載の製造方法。 5、ヒアルロン酸塩がヒアルロン酸ナトリウム、ヒアル
ロン酸カリウム、及びヒアルロン酸カルシウムから選ば
れた1種以上である請求項3記載の製造方法。 6、ヒアルロン酸塩繊維シートからなる皮膚欠損傷用被
覆保護材。
[Claims] 1. A sheet made of hyaluronate fibers. 2. The sheet according to claim 1, wherein the hyaluronate is one or more selected from sodium hyaluronate, potassium hyaluronate, and calcium hyaluronate. 3. Introduce an aqueous hyaluronate solution into the water-soluble organic solvent so that the final concentration is 50 v/v% or more, coagulate and precipitate the fibrous hyaluronate, and then add it to the solution. A method for producing a sheet made of hyaluronate fibers, which comprises crushing the fibers into short fibers, forming the fibers into paper, and drying the fibers. 4. The production method according to claim 3, wherein the water-soluble organic solvent is one or more solvents selected from methanol, ethanol, acetone, n-propanol, iso-propanol, and acetonitrile. 5. The manufacturing method according to claim 3, wherein the hyaluronate is one or more selected from sodium hyaluronate, potassium hyaluronate, and calcium hyaluronate. 6. Covering and protecting material for skin defects made of hyaluronate fiber sheet.
JP1089683A 1989-04-11 1989-04-11 Method for producing hyaluronate sheet Expired - Lifetime JPH0622560B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1089683A JPH0622560B2 (en) 1989-04-11 1989-04-11 Method for producing hyaluronate sheet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1089683A JPH0622560B2 (en) 1989-04-11 1989-04-11 Method for producing hyaluronate sheet

Publications (2)

Publication Number Publication Date
JPH02268765A true JPH02268765A (en) 1990-11-02
JPH0622560B2 JPH0622560B2 (en) 1994-03-30

Family

ID=13977566

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1089683A Expired - Lifetime JPH0622560B2 (en) 1989-04-11 1989-04-11 Method for producing hyaluronate sheet

Country Status (1)

Country Link
JP (1) JPH0622560B2 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5520916A (en) * 1991-12-18 1996-05-28 M.U.R.S.T. (Italian Ministry For Universities And Scientific And Technological Research) Non-woven fabric material comprising hyaluronic acid derivatives
US5622707A (en) * 1991-12-18 1997-04-22 M.U.R.S.T. (Italian Ministry For Universities And Scientific And Technological Research) Composite membranes for the guided regeneration of tissues
JPH09151365A (en) * 1995-11-30 1997-06-10 Tombow Pencil Co Ltd Solid adhesive composition
US5824335A (en) * 1991-12-18 1998-10-20 Dorigatti; Franco Non-woven fabric material comprising auto-crosslinked hyaluronic acid derivatives
JP2014502678A (en) * 2010-12-31 2014-02-03 コンティプロ ビオテック スポレチノスト エス ルチェニム オメゼニム Hyaluronan fiber, its preparation method and use
JP2020527987A (en) * 2017-07-26 2020-09-17 ユーレー カンパニー リミテッドYoureh Co.,Ltd. Wound dressing containing hyaluronic acid-calcium and polylysine and its manufacturing method
KR102338355B1 (en) * 2021-05-17 2021-12-22 주식회사 우럭 Method Of Producing Hyaluronic Acid Non Woven Fabric

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1326883C (en) * 2005-11-04 2007-07-18 山东福瑞达生物化工有限公司 Method for preparing calcium hyauronate

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0214019A (en) * 1988-06-30 1990-01-18 Tonen Corp Fibrous shaped material and production thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0214019A (en) * 1988-06-30 1990-01-18 Tonen Corp Fibrous shaped material and production thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5520916A (en) * 1991-12-18 1996-05-28 M.U.R.S.T. (Italian Ministry For Universities And Scientific And Technological Research) Non-woven fabric material comprising hyaluronic acid derivatives
US5622707A (en) * 1991-12-18 1997-04-22 M.U.R.S.T. (Italian Ministry For Universities And Scientific And Technological Research) Composite membranes for the guided regeneration of tissues
US5824335A (en) * 1991-12-18 1998-10-20 Dorigatti; Franco Non-woven fabric material comprising auto-crosslinked hyaluronic acid derivatives
JPH09151365A (en) * 1995-11-30 1997-06-10 Tombow Pencil Co Ltd Solid adhesive composition
JP2014502678A (en) * 2010-12-31 2014-02-03 コンティプロ ビオテック スポレチノスト エス ルチェニム オメゼニム Hyaluronan fiber, its preparation method and use
JP2020527987A (en) * 2017-07-26 2020-09-17 ユーレー カンパニー リミテッドYoureh Co.,Ltd. Wound dressing containing hyaluronic acid-calcium and polylysine and its manufacturing method
KR102338355B1 (en) * 2021-05-17 2021-12-22 주식회사 우럭 Method Of Producing Hyaluronic Acid Non Woven Fabric
WO2022245059A1 (en) * 2021-05-17 2022-11-24 주식회사 파이버엔텍 Hyaluronate nonwoven fabric and manufacturing method therefor

Also Published As

Publication number Publication date
JPH0622560B2 (en) 1994-03-30

Similar Documents

Publication Publication Date Title
DE69817574T2 (en) MANUFACTURING METHOD FOR A FIBER-FREE, POROUS MATERIAL
DE69231796T2 (en) COMPOSITE FABRIC, CONTAINING DERIVATIVES OF HYALURONIC ACID
EP0199531B1 (en) Wound dressing
KR102006836B1 (en) Method of preparation of polysaccharide fibers, wound covers that contain them, method of manufacturing of wound covers, and apparatus for preparation of polysaccharide fibers
CN103483625B (en) The multi-usage biocompatible materials of absorbable and degradable
JP2000513258A (en) Use of oxidized cellulose and its complexes for chronic wound healing
JPH07502431A (en) Hybrid membranes for guided tissue regeneration
EP0081440A1 (en) Process for preparing forms of native or non-crosslinked collagen with a preserved helicoidal structure, in association with mucopolysaccharides, and their use in the cosmetic, pharmaceutical, analytical and other fields
WO2018214007A1 (en) Antibacterial wound dressing and preparation method and application thereof
JPH02268765A (en) Hyaluronate sheet and preparation thereof
GB2499359A (en) Polysaccharide fibre comprising alginate and psyllium, for wound dressings
JPH0783759B2 (en) Collagen fiber hemostatic material and method for producing the same
CN1298972A (en) Hydro-entangled non-woven chitin fibre cloth and its production method
JPH0835193A (en) Method for producing non-woven collagen fiber sheet
JPS61281131A (en) Production of chitin molded product
CN109260501A (en) A kind of preparation method of Biodegradable wound dressing
CN1687498A (en) Blended fiber of sodium alginate/glutin, preparation method and application thereof
JP3046099B2 (en) Chitin or chitosan floc
JP3599741B2 (en) Alginate fiber, its production method and application
US20200179445A1 (en) Antimicrobial composition comprising a polysaccharide, a stabilizing agent and triiodide, method of preparation thereof and use thereof
CN1068916C (en) Chitin fibers and production thereof
AT508688B1 (en) CARBOXYETHYL CELLULOSE FIBERS, THEIR USE IN WOUND ALLOYS AND HYGIENE ITEMS AND METHOD FOR THE PRODUCTION THEREOF
CN109745577A (en) Preparation method of chitosan-based drug-loaded flexible sponge
CN1027599C (en) Method for producing biological functional medical non-woven fabric and product thereof
JP2660255B2 (en) Alginate fiber, method for producing the same, and product thereof